Filed: 11/4/2022ACC: 0000950123-22-010802
π What this filing means
SYNCONA PORTFOLIO LTD filed this quarterly 13FβHR report disclosing 4 equity positions with a total reported market value of $57.5K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$57.5K
Total AUM (reported)
41.81M
Total Shares
Allocation by class
SPONSORED ADS$40.3K70.1%
SPON ADS$15.7K27.3%
SPONDS ADR$1.5K2.6%
Portfolio Concentration
Top 3$56.1K97.4%
4β10$1.5K2.6%
Top 3 weight
97.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 41.81M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
41.81M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other4
Dominant voting typeShared Β· 100.0% of voting shares
Institutional Holdings4
Rows:
ACHILLES THERAPEUTICS PLC
OTRShares11.09M
TypeSH
Market value$25.1K
43.54%
Sole
0.00
Shared
11.09M
None
0.00
AUTOLUS THERAPEUTICS PLC
OTRShares7.35M
TypeSH
Market value$15.7K
27.32%
Sole
0.00
Shared
7.35M
None
0.00
FREELINE THERAPEUTICS HLDGS
OTRShares22M
TypeSH
Market value$15.3K
26.56%
Sole
0.00
Shared
22M
None
0.00
ADAPTIMMUNE THERAPEUTICS PLC
OTRShares1.38M
TypeSH
Market value$1.5K
2.57%
Sole
0.00
Shared
1.38M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ACHILLES THERAPEUTICS PLCOTR | SPONSORED ADS | 11.09M | SH | $25.1K 43.54% | 0.00 | 11.09M | 0.00 |
AUTOLUS THERAPEUTICS PLCOTR | SPON ADS | 7.35M | SH | $15.7K 27.32% | 0.00 | 7.35M | 0.00 |
FREELINE THERAPEUTICS HLDGSOTR | SPONSORED ADS | 22M | SH | $15.3K 26.56% | 0.00 | 22M | 0.00 |
ADAPTIMMUNE THERAPEUTICS PLCOTR | SPONDS ADR | 1.38M | SH | $1.5K 2.57% | 0.00 | 1.38M | 0.00 |